Z. Mao, IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution, Am. J. Surg. Pathol, vol.31, pp.1605-1614, 2007.

M. Pinti, Aging of the immune system: focus on inflammation and vaccination, Eur. J. Immunol, vol.46, pp.2286-2301, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02452484

N. S. Nicholas, B. Apollonio, and A. G. Ramsay, Tumor microenvironment (TME)-driven immune suppression in B cell malignancy, Biochim. Biophys. Acta, vol.1863, pp.471-482, 2016.

W. Ding, Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL, Blood, vol.129, pp.3419-3427, 2017.

C. Hömig-hölzel, Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis, J. Exp. Med, vol.205, pp.1317-1329, 2008.

M. Boice, Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T, Cells Cell, vol.167, pp.405-418, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01405853

S. Montoto and J. Fitzgibbon, Transformation of indolent B-cell lymphomas, J. Clin. Oncol, vol.29, pp.1827-1834, 2011.

G. Fabbri, Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome, J. Exp. Med, vol.210, pp.2273-2288, 2013.

L. Pasqualucci, Genetics of follicular lymphoma transformation, Cell Rep, vol.6, pp.130-140, 2014.

C. B. Simone, S. H. Burri, and J. H. Heinzerling, Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies, Transl. Lung Cancer Res, vol.4, pp.545-552, 2015.